1. Home
  2. VRAX vs HIHO Comparison

VRAX vs HIHO Comparison

Compare VRAX & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • HIHO
  • Stock Information
  • Founded
  • VRAX 2013
  • HIHO 1990
  • Country
  • VRAX United Kingdom
  • HIHO Hong Kong
  • Employees
  • VRAX N/A
  • HIHO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HIHO Industrial Machinery/Components
  • Sector
  • VRAX Health Care
  • HIHO Industrials
  • Exchange
  • VRAX Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • VRAX 7.3M
  • HIHO 8.2M
  • IPO Year
  • VRAX 2022
  • HIHO 1996
  • Fundamental
  • Price
  • VRAX $1.66
  • HIHO $1.84
  • Analyst Decision
  • VRAX
  • HIHO
  • Analyst Count
  • VRAX 0
  • HIHO 0
  • Target Price
  • VRAX N/A
  • HIHO N/A
  • AVG Volume (30 Days)
  • VRAX 256.7K
  • HIHO 4.3K
  • Earning Date
  • VRAX 02-05-2025
  • HIHO 01-21-2025
  • Dividend Yield
  • VRAX N/A
  • HIHO 6.52%
  • EPS Growth
  • VRAX N/A
  • HIHO N/A
  • EPS
  • VRAX N/A
  • HIHO N/A
  • Revenue
  • VRAX $84,872.00
  • HIHO $7,345,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • HIHO N/A
  • Revenue Next Year
  • VRAX $66.97
  • HIHO N/A
  • P/E Ratio
  • VRAX N/A
  • HIHO N/A
  • Revenue Growth
  • VRAX 7.03
  • HIHO 11.36
  • 52 Week Low
  • VRAX $0.60
  • HIHO $1.70
  • 52 Week High
  • VRAX $9.00
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • HIHO 47.10
  • Support Level
  • VRAX $1.56
  • HIHO $1.83
  • Resistance Level
  • VRAX $1.86
  • HIHO $1.91
  • Average True Range (ATR)
  • VRAX 0.19
  • HIHO 0.04
  • MACD
  • VRAX -0.04
  • HIHO -0.00
  • Stochastic Oscillator
  • VRAX 26.31
  • HIHO 38.62

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.

Share on Social Networks: